| Christopher Aranda, MD | |
|
1946 45th St Ste C, Munster, IN 46321-3986 | |
| (219) 440-5334 | |
| (219) 440-5335 |
| Full Name | Christopher Aranda |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1946 45th St Ste C, Munster, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528551637 | NPI | - | NPPES |
| 000001542304 | Other | IN | ANTHEM |
| 300049089 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 125.071986 (Illinois) | Secondary |
| 208000000X | Pediatrics | 01085510A (Indiana) | Primary |
| Entity Name | Community Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457610487 PECOS PAC ID: 3678737012 Enrollment ID: O20120614000331 |
News Archive
Scientists at the Institute of Molecular Biology (IMB) in Mainz have identified a protein essential for initiating the development of male sex organs. Loss of the gene Gadd45g results in complete sex reversal of male mice, making them appear female.
uniQure announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion that recommends marketing authorization of Glybera (alipogene tiparvovec) as a treatment for lipoprotein lipase deficiency (LPLD) under exceptional circumstances.
Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are likely to command a premium price and fuel growth in developed markets, while heightened access to treatment and larger patient volumes due to more funding for critical care are anticipated to contribute to demand in emerging markets.
Mucus and other airway secretions that are expelled when a person with the flu coughs or exhales appear to protect the virus when it becomes airborne, regardless of humidity levels, a creative experiment conducted by the University of Pittsburgh and Virginia Tech discovered.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Aranda, MD 180 Harvester Dr Ste 110, Burr Ridge, IL 60527-6686 Ph: (773) 702-1150 | Christopher Aranda, MD 1946 45th St Ste C, Munster, IN 46321-3986 Ph: (219) 440-5334 |
News Archive
Scientists at the Institute of Molecular Biology (IMB) in Mainz have identified a protein essential for initiating the development of male sex organs. Loss of the gene Gadd45g results in complete sex reversal of male mice, making them appear female.
uniQure announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion that recommends marketing authorization of Glybera (alipogene tiparvovec) as a treatment for lipoprotein lipase deficiency (LPLD) under exceptional circumstances.
Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are likely to command a premium price and fuel growth in developed markets, while heightened access to treatment and larger patient volumes due to more funding for critical care are anticipated to contribute to demand in emerging markets.
Mucus and other airway secretions that are expelled when a person with the flu coughs or exhales appear to protect the virus when it becomes airborne, regardless of humidity levels, a creative experiment conducted by the University of Pittsburgh and Virginia Tech discovered.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
› Verified 2 days ago
Mrs. Azra Shibli Sheriff, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9128 Columbia Ave, Ste A, Munster, IN 46321 Phone: 219-836-2730 Fax: 219-836-0244 | |
Linda T Chan, M.D Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 800 Macarthur Blvd, Ste 21, Munster, IN 46321 Phone: 219-836-1163 Fax: 219-836-0588 | |
Dr. Eric Heinert, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 9126 Columbia Ave, Munster, IN 46321 Phone: 219-836-1600 | |
Dr. Erica Lynne Yamout, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1946 45th Ave, Munster, IN 46321 Phone: 219-924-7794 | |
Dr. Robert H. Wadle, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7905 Calumet Ave, Hammond Clinic Llc, Munster, IN 46321 Phone: 219-836-7214 Fax: 219-934-9816 | |
Mely Tan Tan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8242 Calumet Ave, Munster, IN 46321 Phone: 219-836-5738 Fax: 219-836-5782 | |
Wichest Boonyapredee, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 901 Macarthur Blvd, Neonatology Department, Munster, IN 46321 Phone: 219-836-2022 |